JAM3 Antikörper (FITC)
(3 Referenzen)-
- Target Alle JAM3 Antikörper anzeigen
- JAM3 (Junctional Adhesion Molecule 3 (JAM3))
-
Reaktivität
- Human, Maus
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser JAM3 Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Produktmerkmale
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
- Immunogen
- Recombinant soluble JAM-C
- Klon
- CRAM-18 F26
- Isotyp
- IgG2a
- Top Product
- Discover our top product JAM3 Primärantikörper
-
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 119-235) antibody
JAM3 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 1-310) antibodyJAM3 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 31-130) antibodyJAM3 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (fro), IF (cc), IF (p), IHC (p), ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 261-295), (C-Term) antibodyJAM3 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal RB47643 unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) antibodyJAM3 Reaktivität: Human, Maus FACS, IHC (fro), IF Wirt: Ratte Monoclonal CRAM-18 F26 unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 82-180) antibodyJAM3 Reaktivität: Human ELISA Wirt: Maus Monoclonal 1D3 unconjugated
anti-Junctional Adhesion Molecule 3 (JAM3) (AA 36-85) antibodyJAM3 Reaktivität: Human, Maus, Meerschweinchen, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.1 mg/mL
-
-
: "Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration." in: Blood, Vol. 100, Issue 7, pp. 2479-86, (2002) (PubMed).
: "JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells." in: The Journal of biological chemistry, Vol. 276, Issue 4, pp. 2733-41, (2001) (PubMed).
: "Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members." in: Blood, Vol. 98, Issue 13, pp. 3699-707, (2001) (PubMed).
-
: "Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration." in: Blood, Vol. 100, Issue 7, pp. 2479-86, (2002) (PubMed).
-
- Target
- JAM3 (Junctional Adhesion Molecule 3 (JAM3))
- Andere Bezeichnung
- JAM-C (JAM3 Produkte)
- Synonyme
- JAM3 antikoerper, jam3 antikoerper, sr:nyz155 antikoerper, wu:fb30h11 antikoerper, wu:fc08c06 antikoerper, wu:fc13e04 antikoerper, wu:fc25g11 antikoerper, jamc.2 antikoerper, 1110002N23Rik antikoerper, JAM-3 antikoerper, JAM-C antikoerper, Jcam3 antikoerper, JAM-2 antikoerper, JAMC antikoerper, junctional adhesion molecule 3 antikoerper, junctional adhesion molecule 3b antikoerper, junctional adhesion molecule 3a antikoerper, junction adhesion molecule 3 antikoerper, JAM3 antikoerper, jam3b antikoerper, jam3a antikoerper, Jam3 antikoerper
- Hintergrund
- Synonyms: JAM-3
- Gen-ID
- 83700, 83964
- UniProt
- Q9BX67, Q9D8B7
-
